ASTH (Astrana Health) Short-Term Debt: $48 Mil (As of Mar. 2026)


ASTH Astrana Health Inc ASTH
87 GF Score
Price $45.02
GF Value $82.34
Valuation Significantly Undervalued
! 8 Warning Signs
View Full Analysis

What is Astrana Health Short-Term Debt?

Astrana Health ASTH +1.35% 87 Short-Term Debt is $48 Mil as of Mar. 2026. GuruFocus rates ASTH with a GF Score™ of 87/100 and a GF Value™ of $82.34 (Significantly Undervalued). The stock has 8 warning signs investors should review.

Astrana Health's Short-Term Debt for the quarter that ended in Mar. 2026 was $48 Mil.

Astrana Health's quarterly Short-Term Debt stayed the same from Sep. 2025 ($48 Mil) to Dec. 2025 ($48 Mil) and stayed the same from Dec. 2025 ($48 Mil) to Mar. 2026 ($48 Mil).

Astrana Health's annual Short-Term Debt declined from Dec. 2023 ($20 Mil) to Dec. 2024 ($9 Mil) but then increased from Dec. 2024 ($9 Mil) to Dec. 2025 ($48 Mil).

Astrana Health Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Astrana Health Short-Term Debt Related Terms

Astrana Health Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Astrana Health's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astrana Health Short-Term Debt Chart

Astrana Health Annual Data
Trend Mar16 Mar17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.78 0.62 19.50 9.38 47.87

Astrana Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.50 12.50 47.87 47.87 47.87
ASTH
87GF Score
Astrana Health Inc ASTH
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $48 Mil mean?
Astrana Health (ASTH) has a Short-Term Debt of $48 Mil as of Mar. 2026.
Is Astrana Health's Short-Term Debt too high?
Astrana Health's current Short-Term Debt is $48 Mil. Overall, Astrana Health has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's Short-Term Debt compare to SGRY and SEM?
Astrana Health's Short-Term Debt of $48 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Healthcare Providers & Services company?
A good Short-Term Debt depends on the Healthcare Providers & Services industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Astrana Health's current Short-Term Debt is $48 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $82.34, compared to a current price of $45.02 — trading 45.3% below its estimated fair value. The current Short-Term Debt is $48 Mil. Astrana Health's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Astrana Health (ASTH), the current Short-Term Debt is $48 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astrana Health (ASTH) Overvalued in 2026?

Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued. The current stock price of $45.02 is trading 45.3% below its estimated GF Value™ of $82.34. GuruFocus considers Astrana Health to be Significantly Undervalued.

Key valuation signals for ASTH:

  • Short-Term Debt: $48 Mil
  • GF Value™: $82.34 vs. price of $45.02 (45.3% below fair value)
  • GF Score™: 87/100 with 8 warning signs

No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Astrana Health Business Description

Other Exchanges 3AM:Germany
Address 1668 South Garfield Avenue, 2nd Floor, Alhambra, CA, USA, 91801
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
87GF Score

Get the complete analysis for ASTH

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$45.02
Price
$82.34
GF Value